Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (s)-(-)-nadifloxacin
1. 154357-42-3
2. (s)-(-)-nadifloxacin
3. 8whh66l098
4. Wck771 Free Base
5. Nadifloxacin, (s)-
6. Wck-771 Free Base
7. Dtxsid70165599
8. Levonadifloxacine
9. Levonadifloxacino
10. Levonadifloxacinum
11. Refchem:924705
12. Dtxcid0088090
13. (5s)-9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1h,5h-benzo(ij)quinolizine-2-carboxylic Acid
14. Levonadifloxacin [inn]
15. (s)-nadifloxacin
16. Wck771
17. (12s)-7-fluoro-8-(4-hydroxypiperidin-1-yl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic Acid
18. 1h,5h-benzo[ij]quinolizine-2-carboxylicacid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (5s)-
19. Chebi:37908
20. Mfcd09954130
21. (s)-9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1h,5h-pyrido[3,2,1-ij]quinoline-2-carboxylic Acid
22. Levonadifloxacin (inn)
23. (5s)-9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1h,5h-pyrido[3,2,1-ij]quinoline-2-carboxylic Acid
24. C19h21fn2o4
25. Unii-8whh66l098
26. Starbld0002875
27. Schembl36594
28. Chembl190561
29. Schembl29390463
30. Gtpl10757
31. Levonadifloxacin [who-dd]
32. Glxc-27365
33. Bdbm50475221
34. (s)-9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidyl)-5-methyl-1-oxo-1h,5h-benzo[i,j]quinolizine-2-carboxylic Acid
35. Da-48828
36. Hy-14926
37. Ms-25695
38. Sy343606
39. Cs-0003639
40. Ns00098910
41. D11933
42. F82021
43. Q27117310
44. (12s)-7-fluoro-8-(4-hydroxy-1-piperidyl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic Acid
45. (5s)-9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic Acid
46. (5s)-9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1h,5h-pyrido[3,2,1-ij]quinolizine-2-carboxylic Acid
47. (s)-(-)-nadifloxacin; 1h,5h-benzo[ij]quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (5s)-; 1h,5h-benzo[ij]quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (s)-; (5s)-9-fluoro-6,7-
48. 1h,5h-benzo[ij]quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (5s)-
49. 1h,5h-benzo[ij]quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (s)-
| Molecular Weight | 360.4 g/mol |
|---|---|
| Molecular Formula | C19H21FN2O4 |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 81.1 |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 631 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
beta-Lactamase Inhibitors
Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES.
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01M - Quinolone antibacterials
J01MA - Fluoroquinolones
J01MA24 - Levonadifloxacin
ABOUT THIS PAGE
41
PharmaCompass offers a list of Levonadifloxacin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Levonadifloxacin manufacturer or Levonadifloxacin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levonadifloxacin manufacturer or Levonadifloxacin supplier.
A Levonadifloxacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levonadifloxacin, including repackagers and relabelers. The FDA regulates Levonadifloxacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levonadifloxacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levonadifloxacin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Levonadifloxacin supplier is an individual or a company that provides Levonadifloxacin active pharmaceutical ingredient (API) or Levonadifloxacin finished formulations upon request. The Levonadifloxacin suppliers may include Levonadifloxacin API manufacturers, exporters, distributors and traders.
click here to find a list of Levonadifloxacin suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
Levonadifloxacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levonadifloxacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Levonadifloxacin GMP manufacturer or Levonadifloxacin GMP API supplier for your needs.
A Levonadifloxacin CoA (Certificate of Analysis) is a formal document that attests to Levonadifloxacin's compliance with Levonadifloxacin specifications and serves as a tool for batch-level quality control.
Levonadifloxacin CoA mostly includes findings from lab analyses of a specific batch. For each Levonadifloxacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levonadifloxacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Levonadifloxacin EP), Levonadifloxacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levonadifloxacin USP).
